Schizophrenia Research
Volume 123, Issue 2 , Pages 276-277, November 2010

A head-to-head comparison of sertindole and risperidone on metabolic parameters☆

  • Marc De Hert

      Affiliations

    • University Psychiatric Center Catholic University Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
    • Corresponding Author InformationCorresponding author. UPC KUL campus Kortenberg, Leuvensesteenweg 517, 3070 Kortenberg, Belgium. Tel.: +32 2 758 05 11; fax: +32 2 759 98 78.
    • ,
  • Aurélia Mittoux

      Affiliations

    • H. Lundbeck A/S, Ottiliavej 9, Valby, Copenhagen, Denmark
    • ,
  • Yuan He

      Affiliations

    • H. Lundbeck A/S, Ottiliavej 9, Valby, Copenhagen, Denmark
    • ,
  • Joseph Peuskens

      Affiliations

    • University Psychiatric Center Catholic University Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium

Received 29 March 2010; received in revised form 19 July 2010; accepted 27 July 2010. published online 23 August 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Clinical trial registration: Safety study of sertindole versus risperidone under normal conditions of use. NCT 00856583 (EudraCT 2004-000213-19). http://clinicaltrials.gov/ct2/results?term=00856583.

PII: S0920-9964(10)01446-5

doi:10.1016/j.schres.2010.07.030

Schizophrenia Research
Volume 123, Issue 2 , Pages 276-277, November 2010

Article Tools

* Image Usage & Resolution